0000899243-20-032694.txt : 20201203
0000899243-20-032694.hdr.sgml : 20201203
20201203190336
ACCESSION NUMBER: 0000899243-20-032694
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201201
FILED AS OF DATE: 20201203
DATE AS OF CHANGE: 20201203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanna Bastiano
CENTRAL INDEX KEY: 0001829069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 201368148
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adicet Bio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: resTORbio, Inc.
DATE OF NAME CHANGE: 20171024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-01
0
0001720580
Adicet Bio, Inc.
ACET
0001829069
Sanna Bastiano
C/O ADICET BIO, INC.
500 BOYLSTON STREET, 13TH FLOOR
BOSTON
MA
02116
1
0
0
0
Stock Option (Right to Buy)
12.00
2020-12-01
4
A
0
28828
0.00
A
2030-11-30
Common Stock
28828
28828
D
33% of the shares shall become exercisable on December 1, 2021, and the remaining 67% of the shares shall vest in 24 equal monthly installments thereafter.
/s/ Nick Harvey, Attorney-in-Fact
2020-12-03